Literature DB >> 30073442

[Percutaneous coronary intervention in stable angina pectoris : Objective randomised blinded investigation with optimal medical therapy of angioplasty in stable angina (ORBITA) trial].

C Kugler1, J Wöhrle2, S Nitschmann3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30073442     DOI： 10.1007/s00108-018-0472-8

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  3 in total

Review 1.  Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials.

Authors:  Seema Pursnani; Frederick Korley; Ravindra Gopaul; Pushkar Kanade; Newry Chandra; Richard E Shaw; Sripal Bangalore
Journal:  Circ Cardiovasc Interv       Date:  2012-08-07       Impact factor: 6.546

2.  Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease: Three-Year Follow-Up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation).

Authors:  William F Fearon; Takeshi Nishi; Bernard De Bruyne; Derek B Boothroyd; Emanuele Barbato; Pim Tonino; Peter Jüni; Nico H J Pijls; Mark A Hlatky
Journal:  Circulation       Date:  2017-11-02       Impact factor: 29.690

3.  Optimal medical therapy with or without PCI for stable coronary disease.

Authors:  William E Boden; Robert A O'Rourke; Koon K Teo; Pamela M Hartigan; David J Maron; William J Kostuk; Merril Knudtson; Marcin Dada; Paul Casperson; Crystal L Harris; Bernard R Chaitman; Leslee Shaw; Gilbert Gosselin; Shah Nawaz; Lawrence M Title; Gerald Gau; Alvin S Blaustein; David C Booth; Eric R Bates; John A Spertus; Daniel S Berman; G B John Mancini; William S Weintraub
Journal:  N Engl J Med       Date:  2007-03-26       Impact factor: 91.245
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.